Wednesday, October 06, 2021 3:23:06 PM
In my head I had that korea would recruit 20 pts, but I cannot find that info anymore. Do you have any source for the 50 pts ?
On July 22nd, South Korea announced a phase I lenzilumab safety trial of 20 patients. It wasn't part of the ACTIV-5 trial.
https://ih.advfn.com/stock-market/NASDAQ/humanigen-HGEN/stock-news/85648204/humanigen-s-partner-in-south-korea-receives-minis
On August 30th, it was announced that 50 patients in the ACTIV-5 would be enrolled in South Korea.
#lenzilumab BET-B study has been approved in South Korea just now.
— gbe_estory (@EstoryGbe) August 30, 2021
50 out of 400 patients will be selected in Korea.$hgen $telcon $kpmtech #remdesivir vs #lenzilumab pic.twitter.com/HMVZpUvjAL
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
